专利号:US-6881847-B2 优先权日:2001-02-01 标题:Process for the synthesis and recovery of nitramines 发明人:HIGHSMITH THOMAS K; HANKS JAMI M; VELARDE STEPHEN P; BOTTARO JEFFREY 权利人:ALLIANT TECHSYSTEMS INC 摘要:A method is provided for the synthesis of nitramines and the recovery of the nitramines from a clathrate.
专利号:US-2012149888-A1 优先权日:2009-02-22 标 题:Synthesis of ara-2'-o-methyl-nucleosides, corresponding phosphoramidites and oligonucleotides incorporating novel modifications for biological application in therapeuctics, diagnostics, g- tetrad forming oligonucleotides and aptamers 发明人:SRIVASTAVA SURESH C; PANDEY DIVYA; SRIVASTAVA NAVEEN P; SRIVASTAVA ALOK 权利人:SRIVASTAVA SURESH C; PANDEY DIVYA; SRIVASTAVA NAVEEN P; SRIVASTAVA ALOK 摘要:The present invention relates to synthesis, purification and methods to obtain high purity novel 2′-arabino-O-methyl nucleosides and the corresponding phosphoramidites of various arabinonucleoside bases and introduction of such units into defined sequence synthetic DNA and RNA. Various synthetic oligonucleotides, such as HIV integrase inhibitor 14-mer and thrombin binding oligonucleotide, thrombin-1, bearing ara-2′-omethyl modification have been synthesized. It is anticipated the oligonucleotides incorporating these monomers will exhibit biological activities related to antisense approach approach, design of better SiRNA's, diagnostic agents. Similarly, it is anticipated that oligonucleotides incorporating such novel nucleosides will be useful to develop therapeutic candidates designing stable G-quadruplexes and Aptamers for oligonucleotide structure, folding topology, evaluation of biochemical properties and design and develop as therapeutic agents. It is further anticipated that the nucleosides, phosphates and triphosphates of this invention could develop as therapeutic agents.
专利号:US-10737239-B2 优先权日:2015-11-27 标题 :Ultrafast high space-time-yield synthesis of metal-organic frameworks 发明人:BURCKHART JULIA; MARX STEFAN; ARNOLD LENA; HOFMANN CLAUS; Müller Ulrich 权利人:BASF SE 摘要:The invention relates to a process for the preparation of metal-organic frameworks (MOFs) in form of a homogenous powder, and a process wherein the metal-organic framework is molded into shaped bodies.
专利号:US-11472779-B1 优先权日:2022-05-13 标 题 :One-pot synthesis of hydrogen-bonded organic frameworks 发明人:KHAN MOHD YUSUF; KHAN ABUZAR; HELAL AASIF; YAMANI ZAIN H 权利人:UNIV KING FAHD PET & MINERALS 摘要:A hydrogen-bonded organic framework (HOF) and a method of making the HOF. The HOF has at least one amine substituted organic linker and at least one carboxylic acid-based organic linker. The HOF is prepared by dissolving the linkers separately in water and mixing the aqueous solutions, without using any organic solvents, additional catalysts, or any other reagents.
专利号:US-4236014-A 优先权日:1979-11-07 标 题:Production of the ammonium salt of 3,5-dinitro-1,2,4-triazole by solvent extraction 发明人:LEE KIEN Y; OTT DONALD G 权利人:US ENERGY 摘要:The ammonium salt of 3,5-dinitro-1,2,4-triazole has utility as a chemical explosive. In accordance with the present invention, it may readily be produced by solvent extraction using high-molecular weight, water-insoluble amines followed by amination with anhydrous ammonia gas. The aqueous reaction mixture produced in the synthesis of the parent compound, 3,5-dinitro-1,2,4-triazole, is quite suitable--and indeed is preferred--for use as the feed material in the process of the invention.
专利号:US-8399502-B2 优先权日:2008-09-17 标 题 :Analogs of indole-3-carbinol and their use as agents against infection 发明人:JONG LING; JIANG FAMING; LI GAOQUAN; MORTELMANS KRISTIEN 权利人:JONG LING; JIANG FAMING; LI GAOQUAN; MORTELMANS KRISTIEN; STANFORD RES INST INT 摘要:Compounds useful as antibacterial agents are provided. The compounds are analogs of indole-3-carbinol and have a backbone selected from dihydroindolo[2,3-b]carbazole, 2,2′-diindolylmethane, 2′,3-diindolylmethane, and 3,3′-diindolylmethane. The compounds are useful therapeutic and prophylactic treatment of bacterial infections in mammals. Methods of synthesis of the compounds are provided, as are pharmaceutical compositions containing the compounds.
1: Moore EC, Hurlbert RB. The inhibition of ribonucleoside diphosphate reductase by hydroxyurea, guanazole and pyrazoloimidazole (IMPY). Pharmacol Ther. 1985;27(2):167-96. doi: 10.1016/0163-7258(85)90068-3. 22(1):foac014. doi: 10.1093/femsyr/foac014. 3: Mys'kiv M, Goreshnik E. Bis[bis-(3,5-diamino-1H-1,2,4-triazol-4-ium)copper(I)] tris-(hexa- fluoridosilicate). Acta Crystallogr Sect E Struct Rep Online. 2010 Oct 23;66(Pt 11):m1453-4. doi: 10.1107/S160053681004225X. 4: Dave C, Higby D, Mattern J, Holland JF, Grace JT. Pharmacokinetics of guanazole in patients with acute myelocytic leukemia. Clin Pharmacol Ther. 1975 Jan;17(1):36-43. doi: 10.1002/cpt197517136. 70(11):1281-3. doi: 10.1002/jps.2600701126. 47(11):4861-76. doi: 10.1021/ic8001042. Epub 2008 May 2. 38(1):36-41. doi: 10.1002/1097-0142(197607)38:1<36::aid- cncr2820380107>3.0.co;2-m. 59(6):1117-21. 231(2):251-64. doi: 10.1016/0027-5107(90)90031-x. 58(5 Pt 1):715-7. 53(1):578-93. doi: 10.1021/ic4027249. Epub 2013 Dec 12. 16(1):108-19. doi: 10.1016/0041-008x(70)90167-5. 70(7):913-4. 148(1):118-22. doi: 10.3181/00379727-148-38488. 71(3):265-70. doi: 10.1023/a:1000123216769. 33(5):972-5.
合成参考文献
参考文献:10.1107/s1600536811011147 摘要:Yousuf S, Johnson AS, Kazmi SA, Offiong OE, Fun HK. 3,5-Diamino-4H-1,2,4-triazol-1-ium (6-carb-oxy-pyridine-2-carboxyl-ato)(pyridine-2,6-dicarboxyl-ato)cuprate(II) trihydrate. Acta Crystallogr Sect E Struct Rep Online. 2011 Apr 01;67(Pt 4):m509–10.